Search results
Results from the WOW.Com Content Network
Meibomian glands in the lower eyelid imaged under amber light to show vasculature support and the gland structure. Meibomian gland dysfunction (MGD, also meibomitis or meibomianitis) is a chronic disease of the meibomian glands, which is commonly characterized by obstruction of the end of the duct that delivers the secretion produced by the glands (called meibum) to the eye surface, which ...
Meibomian gland dysfunction is more often seen in women and is regarded as the main cause of dry eye disease. [ 14 ] [ 15 ] Factors that contribute to meibomian gland dysfunction can include things such as a person's age and/or hormones, [ 16 ] or severe infestation of Demodex brevis mite.
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
The Food and Drug Administration (FDA) has not approved antibiotics for this use and it is considered 'off-label'. Concerns about this procedure contributing to increasing numbers of antibiotic resistant bacteria have been expressed. [1] In the UK, Aprokam cefuroxime has been approved for use in intracameral injections. [2]
The most common cause of dry eye is increased evaporation of the tear film, typically as a result of meibomian gland dysfunction (MGD). The meibomian glands are two sets of oil glands that line the upper and lower eyelids and secrete the oily outer layer of the tear film—the lipid layer. These glands often become clogged due to inflammation ...
Isotretinoin is known to cause meibomian gland dysfunction which causes persistent keratoconjunctivitis sicca (dry eye). [44] Problems with the meibomian and salivary glands are likely due to the non-selective apoptosis of the cells of the exocrine glands. [45]
Intense pulsed light (IPL) is a technology used by cosmetic and medical practitioners to perform various skin treatments for aesthetic and therapeutic purposes, including hair removal, photorejuvenation (e.g. the treatment of skin pigmentation, sun damage, and thread veins) as well as to alleviate dermatologic diseases such as acne.
A review of treatments showed that the anti-mite drug ivermectin can be an effective treatment for reducing symptoms. [24] Eye drops or ointments containing corticosteroids are frequently used in conjunction with antibiotics and can reduce eyelid inflammation. [4] [5] [25] The supplement n-acetylcysteine may be effective for blepharitis. [26]